All About Youth: Evaluation of Sexual Risk Avoidance and Risk Reduction Programs for Middle School Students
This study will evaluate the efficacy of two curricula relative to standard care. The first is a sexual risk avoidance curriculum for middle school students that included abstinence until marriage and complies with Title V Section 510 A-H abstinence education requirements. The second is a sexual risk reduction curriculum for middle school students that included abstinence and condom/contraceptive...
Brief Summary
Official Title: “SIP 4-04 Evaluation of Abstinence-Only and Abstinence-Plus Program to Prevent HIV, STD, and Pregnancy Among Middle School Students”
This study will evaluate the efficacy of two curricula relative to standard care. The first is a sexual risk avoidance curriculum for middle school students that included abstinence until marriage and complies with Title V Section 510 A-H abstinence education requirements.
The second is a sexual risk reduction curriculum for middle school students that included abstinence and condom/contraceptive information and skills. Each intervention consists of an age-appropriate classroom curriculum and a CD-ROM-based tailored intervention delivered in 7th and 8th grade. The overall goal of the study is to identify common elements of effective sexuality education curricula that will be of benefit to youth.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
- Study Primary Completion Date: July 2010
Detailed Clinical Trial Description
This study will evaluate the efficacy of a risk avoidance program for middle school students and a theoretically-comparable risk reduction program relative to standard care. The study design is a randomized controlled trial conducted in fifteen inner-city middle schools in Houston, Texas. Five schools were randomly assigned to a risk avoidance intervention, five to a risk reduction intervention, and five to a comparison (standard care) condition.
Approximately, 1,800 7th grade students were recruited into the study and will be followed over a three-year period. Based on a formative study, a pilot study, and input from community groups and a national panel of experts, two comparable curricula were developed.
The risk avoidance curriculum emphasizes sexual abstinence until marriage and includes the requirements for abstinence education as defined in Title V, Section 510. The risk reduction curriculum emphasizes abstinence and addresses condom and contraceptive use. The risk avoidance and risk reduction interventions each consist of an age-appropriate classroom curriculum and a CD-ROM-based tailored intervention delivered in 7th and 8th grade. Each intervention was delivered by trained facilitators. The effect of the interventions will be evaluated by assessing sexual risk-taking behaviors of participants in each intervention (proportion of students initiating sexual intercourse, proportion that are sexually active, number of times of unprotected sex, number of sexual partners) relative to the comparison group. Risk assessment data from students was collected by using an audio computer-assisted self-interview (ACASI) approach for the collection of baseline, 6-, 18-, and 24-month data.
Parental permission and child assent were required prior to participation. In addition, we will conduct a 36-month follow-up survey and a one-time urine-based test for chlamydia, gonorrhea, and trichomonas which will provide additional longitudinal data to assess the impact of each curriculum, relative to standard care.
Intervention(s) in this Clinical Trial
- Behavioral: Risk Avoidance Intervention
- The risk avoidance intervention is a Title V compliant curriculum emphasizing abstinence until marriage and strong character development. The curriculum includes 12 classroom and CD-ROM based lessons delivered in the 7th and 8th grade. Lessons include topics such as puberty, reproduction, healthy relationships, consequences of sex, and refusal skills.
- Behavioral: Risk Reduction Intervention
- The risk reduction intervention is a curriculum providing skills for abstinence and condom and other contraceptive use. The curriculum includes 12 classroom and CD-ROM based lessons delivered in the 7th and 8th grade. Lessons include topics such as puberty, reproduction, healthy relationships, consequences of sex, and refusal skills.
Arms, Groups and Cohorts in this Clinical Trial
- Experimental: Risk Avoidance
- The risk avoidance intervention is a Title V compliant curriculum emphasizing abstinence until marriage and strong character development. The curriculum includes both classroom and CD-ROM based lessons delivered in the 7th and 8th grade. Lessons include topics such as puberty, reproduction, healthy relationships, consequences of sex, and refusal skills.
- Experimental: Risk Reduction
- The risk reduction intervention is a curriculum providing skills for abstinence and condom and other contraceptive use. The curriculum includes both classroom and CD-ROM based lessons delivered in the 7th and 8th grade. Lessons include topics such as puberty, reproduction, healthy relationships, consequences of sex, and refusal skills.
Outcome Measures for this Clinical Trial
Primary Measures
- delay onset of sex
- Time Frame: baseline, 6,18, 24, and 36 month follow-up
Safety Issue?: No
- Time Frame: baseline, 6,18, 24, and 36 month follow-up
Secondary Measures
- knowledge
- Time Frame: baseline, 6,18, 24, and 36 month follow-up
Safety Issue?: No
- Time Frame: baseline, 6,18, 24, and 36 month follow-up
- skills
- Time Frame: baseline, 6, 18, 24, and 36 month follow-up
Safety Issue?: No
- Time Frame: baseline, 6, 18, 24, and 36 month follow-up
- self-efficacy
- Time Frame: baseline, 6, 18, 24, and 36 month follow-up
Safety Issue?: No
- Time Frame: baseline, 6, 18, 24, and 36 month follow-up
- attitudes
- Time Frame: baseline, 6, 18, 24, and 36 month follow-up
Safety Issue?: No
- Time Frame: baseline, 6, 18, 24, and 36 month follow-up
- condom use
- Time Frame: baseline, 6, 18, 24, and 36 month follow-up
Safety Issue?: No
- Time Frame: baseline, 6, 18, 24, and 36 month follow-up
- alcohol/drug use
- Time Frame: baseline, 6, 18, 24, and 36 month follow-up
Safety Issue?: No
- Time Frame: baseline, 6, 18, 24, and 36 month follow-up
- number of sexual partners
- Time Frame: baseline, 6, 18, 24, and 36 month follow-up
Safety Issue?: No
- Time Frame: baseline, 6, 18, 24, and 36 month follow-up
- prevalence of chlamydia, gonorrhea, and trichomonas
- Time Frame: 36-month follow-up
Safety Issue?: No
- Time Frame: 36-month follow-up
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- 7th graders attending regular classes in Houston Independent School District
Exclusion Criteria:
- No students will be excluded based on race/ethnicity, age, or gender
- Students will be informed that the surveys and intervention materials will only be available in English and will be asked to consider their comfort level with participating in the study.
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 11 Years
Maximum Age for this Clinical Trial: 16 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers
Clinical Trial Investigator Information
Lead Investigator: The University of Texas Health Science Center, Houston Other
Overall Clinical Trial Officials and Contacts
Christine Markham, PhD Principal Investigator University of Texas Houston School of Public Health
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00167505
Study ID Number: U48/DP000057
ClinicalTrials.gov Identifier: NCT00167505
Health Authority: United States: Institutional Review Board
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00167505
